Formulation patents often persist after the composition of matter patent(s) on a drug have expired or have been declared invalid. Thus, if US generic drugs were required to have the identical inactive ingredients as their branded counterparts, many branded drugs would have longer periods of marketing exclusivity and there would be fewer generic drugs on the market.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”